Medicare Enrolled

Dr. Douglas Kelling, MD

Pulmonary Disease · Concord, NC
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
200 MEDICAL PARK DR, Concord, NC 28025
7044031307
Registered in NPPES since 2006
NPI: 1396717708 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Kelling from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Kelling? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Kelling

Dr. Douglas Kelling is a pulmonary disease specialist in Concord, NC, with 20 years of NPI registration. Based on federal Medicare data, Dr. Kelling performed 3,977 Medicare services in 2023. These records do not provide a deduplicated patient total.

Between the years covered by Open Payments, Dr. Kelling received a total of $126,358 from 24 pharmaceutical and/or device companies across 316 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Kelling is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years of NPI registration ▲ Top 6% volume in NC $126,358 industry payments

Medicare Practice Summary — 2023

Medicare Utilization ↗
3,977
Medicare services
Top 6% in NC for pulmonary disease
Not available
Unique patients (not deduplicated)
$34
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Denosumab injection (Prolia/Xgeva) 2,520 $18 $76
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
653 $86 $310
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
229 $65 $220
Office visit for established patient
An office visit for an existing patient that may not require the healthcare professional to be present.
119 $16 $68
Hemoglobin A1c test (diabetes monitoring)
A blood test that measures your average blood sugar levels over the past two to three months.
102 $10 $47
Annual wellness visit, follow-up
A follow-up annual wellness visit that includes a personalized prevention plan of service.
75 $125 $328
Prothrombin time test (blood clotting)
A laboratory test that measures how long it takes for blood to clot. This procedure evaluates the body's coagulation process.
73 $4 $17
Flu vaccine, high-dose
High-dose seasonal influenza vaccine for adults aged 65 and older. Contains four times the antigen of standard-dose flu vaccines (60 mcg per strain), split-virus formulation, preservative-free, single-dose syringe.
53 $71 $152
Flu vaccine administration
This procedure involves the administration of the influenza virus vaccine. It covers the process of delivering the vaccine to the patient.
53 $29 $50
Drug injection, under skin or into muscle
A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle.
45 $10 $75
Continuous glucose monitoring with interpretation
This procedure involves monitoring blood sugar levels in tissue fluid using a sensor placed under the skin, along with the interpretation and reporting of the results.
41 $24 $120
COVID-19 amplified DNA/RNA probe detection
A laboratory test that uses amplified DNA or RNA probes to detect the presence of severe acute respiratory syndrome coronavirus 2 (COVID-19) antigen.
14 $50 $167
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.

Industry Payment Transparency

Open Payments through 2024 ↗
$126,358
Total received (2018-2024)
Avg $18,051/year across 7 years
Top 3% in NC for pulmonary disease
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
24
Companies
316
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →

Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$877
2023
$144
2022
$2,728
2021
$9,410
2020
$14,206
2019
$56,459
2018
$42,534

Payments by company (2024)

Insulet Corporation
$249
Lilly USA, LLC
$214
PFIZER INC.
$135
Novo Nordisk Inc
$89
GlaxoSmithKline, LLC.
$55
Boehringer Ingelheim Pharmaceuticals, Inc.
$48
E.R. Squibb & Sons, L.L.C.
$37
Dynavax Technologies Corporation
$19
Merck Sharp & Dohme LLC
$17
Novartis Pharmaceuticals Corporation
$15
Top 3 companies account for 68.2% of 2024 payments
All-time payments by company (2018-2024) ›
Mylan Specialty L.P.
$32,151
Regeneron Healthcare Solutions, Inc.
$19,102
Sunovion Pharmaceuticals Inc.
$15,260
SANOFI PASTEUR INC.
$9,734
GlaxoSmithKline, LLC.
$8,551
AstraZeneca Pharmaceuticals LP
$8,261
Amgen Inc.
$6,551
Sanofi Pasteur Inc.
$5,472
Teva Pharmaceuticals USA, Inc.
$4,359
E.R. Squibb & Sons, L.L.C.
$4,226
ViiV Healthcare Company
$3,489
Novo Nordisk Inc
$2,665
GENZYME CORPORATION
$2,111
Novartis Pharmaceuticals Corporation
$2,009
Genentech USA, Inc.
$1,455
Insulet Corporation
$249
Lilly USA, LLC
$235
PFIZER INC.
$218
Boehringer Ingelheim Pharmaceuticals, Inc.
$77
Boston Scientific Corporation
$74
Merck Sharp & Dohme LLC
$37
SANOFI-AVENTIS U.S. LLC
$29
CSL Behring
$24
Dynavax Technologies Corporation
$19
Top 3 companies account for 52.6% of all-time payments
Associated products mentioned in payments ›
ANORO · AREXVY · BREZTRI · BREZTRI AEROSPHERE · CHANTIX · CINQAIR · DUPIXENT · ELIQUIS · ENTRESTO · FARXIGA · FASENRA · FLUBLOK QUADRIVALENT · FLUZONE HIGH-DOSE · GARDASIL · Heplisav-B · JARDIANCE · LEQVIO · LOKELMA · LONHALA MAGNAIR · LYRICA · MOUNJARO · NUCALA · NURTEC ODT · Omnipod · Ozempic · PRALUENT ALIROCUMAB INJECTION · RYBELSUS · Repatha · Rybelsus · SHINGRIX · Saxenda · TRELEGY ELLIPTA · WATCHMAN · Wegovy · Xolair · YUPELRI · Yupelri · Zemaira
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Looking for a pulmonary disease specialist in Concord?
Compare pulmonary diseases in the Concord area by procedure volume, costs, and industry payment transparency.
Browse pulmonary diseases nearby

Geographic Context

Pulmonary diseases in nearby ZIP areas
27
County median income
$86,084
Nearest hospital to ZIP centroid (approximate)
CAROLINAS MEDICAL CENTER-NORTHEAST
0.0 mi

Data Sources

Provider Registry NPPES NPPES snapshot; verify current record
Medicare Enrollment PECOS PECOS snapshot
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not included N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Kelling is a clinical cardiology specialist, with above-average Medicare volume (top 6% in NC), with 20 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Kelling experienced with denosumab injection (prolia/xgeva)?
Based on Medicare claims data, Dr. Kelling performed 2,520 denosumab injection (prolia/xgeva) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Kelling receive payments from pharmaceutical companies?
Yes. Dr. Kelling received a total of $126,358 from 24 companies across 316 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Kelling's costs compare to other pulmonary diseases in Concord?
Dr. Kelling's average Medicare payment per service is $34. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Kelling) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
About this page

This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Industry payment disclosure alone establishes neither wrongdoing nor legality. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →